Nueva EPS will be subjected to inspection and surveillance after the death of a minor with hemophilia in Bogotá
The death of Kevin Arley Acosta Pico, a 7-year-old minor diagnosed with severe hemophilia A complicated by inhibitors, caused indignation due to the care provided within the General System of Social Security in Health (SGSSS).
TL;DR
- Kevin Arley Acosta Pico, a 7-year-old boy with severe hemophilia A, died on February 13, 2026, in Bogotá.
- His death followed a severe head injury sustained during a sports accident.
- The family and the Colombian League of Hemophilia have denounced the attention provided by the SGSSS.
- The family claims the boy did not receive Emicizumab (Hemlibra) for approximately two months.
- The National Superintendency of Health has initiated an inspection and surveillance action against Nueva EPS.
- The inspection will review administrative barriers, authorization processes, medical protocols, and medication delivery.
- The Superintendency warned that administrative sanctions, fines, or corrective measures could be imposed if irregularities are found.